Protagonist Therapeutics Inc (PTGX)
Free Cash Flow Growth
839.65%
Quarterly · Period ending:
PTGX Free Cash Flow Growth
Year-over-year change vs the same period a year earlier
Latest reported839.65%period ending
Latest reported839.65%period ending
PTGX Quarterly Free Cash Flow YoY % (-125.18% → 839.65%)
Year-over-year change
High-resolution chart · PNG
PTGX free cash flow growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Free Cash Flow Growth |
|---|---|
| 839.6479% | |
| -139.3837% | |
| -20.4863% | |
| 92.929% | |
| -111.0177% | |
| 551.0787% | |
| -274.0629% | |
| -6.0078% | |
| 1,116.8623% | |
| 19.4604% | |
| 153.4332% | |
| -6.5134% | |
| -89.6876% | |
| 9.4415% | |
| -16.8417% | |
| 11.7348% | |
| 42.4587% | |
| -31.295% | |
| -42.8759% | |
| -75.6203% | |
| -11.9593% | |
| -80.7582% | |
| -30.9161% | |
| -17.3997% | |
| -878.0778% | |
| 5.0036% | |
| -42.2673% | |
| -47.8884% | |
| 117.962% | |
| -9.6572% | |
| 28.2154% | |
| -123.2611% | |
| -21.7891% | |
| -47.501% | |
| -45.9618% | |
| 676.4656% | |
| -56.7584% | |
| -89.5082% | |
| -96.2492% | |
| -81.0407% | |
| -131.127% | |
| -125.1846% |